These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


418 related items for PubMed ID: 8435908

  • 1. Calcipotriol. A new topical antipsoriatic.
    Kragballe K, Iversen L.
    Dermatol Clin; 1993 Jan; 11(1):137-41. PubMed ID: 8435908
    [Abstract] [Full Text] [Related]

  • 2. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M, Mrowietz U, Koenig M, Simon JC.
    Eur J Dermatol; 2003 Jan; 13(3):261-5. PubMed ID: 12804986
    [Abstract] [Full Text] [Related]

  • 3. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P, Andres P.
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [Abstract] [Full Text] [Related]

  • 4. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC, van der Valk PG, Swinkels OQ, Kucharekova M, de Rie MA, de Vries HJ, Damstra R, Oranje AP, de Waard-van der Spek FB, van Neer P, Lijnen RL, Kunkeler AC, van Hees C, Haertlein NG, Hol CW.
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [Abstract] [Full Text] [Related]

  • 5. Calcipotriol ointment. A review of its use in the management of psoriasis.
    Scott LJ, Dunn CJ, Goa KL.
    Am J Clin Dermatol; 2001 Oct; 2(2):95-120. PubMed ID: 11705309
    [Abstract] [Full Text] [Related]

  • 6. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, Oranje AP, de Rie MA, de Waard-van der Spek FB, Hol CW, van de Kerkhof PC.
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [Abstract] [Full Text] [Related]

  • 7. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903).
    Kragballe K.
    Arch Dermatol; 1989 Dec; 125(12):1647-52. PubMed ID: 2531570
    [Abstract] [Full Text] [Related]

  • 8. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G, Aldebani S, Elzorghany A, Benghazil M, Alhaddar J.
    Int J Clin Pharmacol Res; 2003 Dec; 23(2-3):47-51. PubMed ID: 15018018
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study.
    Kragballe K, Fogh K, Søgaard H.
    Acta Derm Venereol; 1991 Dec; 71(6):475-8. PubMed ID: 1685828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC.
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [Abstract] [Full Text] [Related]

  • 14. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J, Bjerke JR, Gjertsen BT, Helland S, Livden JK, Morken T, Mørk NJ.
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [Abstract] [Full Text] [Related]

  • 15. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP, Van Erp PE, Van De Kerkhof PC.
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [Abstract] [Full Text] [Related]

  • 16. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
    Kragballe K, Steijlen PM, Ibsen HH, van de Kerkhof PC, Esmann J, Sorensen LH, Axelsen MB.
    Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Topical calcipotriol (MC 903) for psoriasis: a clinical study.
    Mozzanica N, Cattaneo A, Schmitt E, Legori A, Finzi AF.
    Acta Derm Venereol Suppl (Stockh); 1994 May; 186():169-70. PubMed ID: 8073826
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.